Therwil, Switzerland

Jürg Zimmermann

This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jürg Zimmermann. Retrieved from https://idiyas.com/inventor/janduumlrg-zimmermann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jürg Zimmermann: Innovator in Medicinal Chemistry

Introduction

Jürg Zimmermann is a notable inventor based in Therwil, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative research and development efforts.

Latest Patents

Zimmermann holds a patent for "2-amino-6-anilino-purines and their use as medicaments." This invention highlights his focus on creating effective medicinal compounds that can potentially improve health outcomes.

Career Highlights

He is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to medicinal chemistry.

Collaborations

Some of his notable coworkers include Patricia Imbach and Hans-Georg Capraro. Their collaborative efforts have likely played a role in advancing the research and development of innovative medicinal products.

Conclusion

Jürg Zimmermann's work exemplifies the impact of innovation in the pharmaceutical industry. His patent and contributions to Novartis AG underscore the importance of research in developing new medicaments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…